Search For "drugs controller general of india dcgi"
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 5 years ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in
Updated : 5 years, 1 month ago IST
New Delhi [India], June 3 (ANI): A Fresh application was moved in Delhi High Court on Thursday seeking to stay the operation of the order of Drugs Controller General of India (DCGI) for conducting phase II/III clinical trials of Whole Virion Inactivated Coronavirus Vaccine in the 2 to 18 yea
Read More
DCGI waiver likely to bring foreign vaccines like Pfizer, Moderna a step c
Updated : 5 years, 1 month ago IST
New Delhi [India], June 2 (ANI): The Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other international regulatory bodies - a big move likely to clear the way for foreign vaccines like Pfizer and Moderna for the
Read More
Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibo
Updated : 5 years, 1 month ago IST
New Delhi [India], May 27 (ANI): Zydus Cadila has sought approval from the Drugs Controller General of India (DCGI) to undertake clinical trials for monoclonal antibodies cocktail that can neutralise COVID-19 infection, the pharmaceutical manufacturer informed on Thursday.
Read More
DCGI approves Phase 2, 3 clinical trials of COVAXIN on children aged 2 to
Updated : 5 years, 2 months ago IST
New Delhi [India], May 13 (ANI): The Drugs Controller General of India (DCGI) on Thursday approved Phase 2 and 3 clinical trial of Bharat Biotech's COVAXIN vaccine in the age group of 2 to 18 years, informed the Ministry of Health and Family Welfare.
Read More
DRDO's anti-COVID 2-DG drug effective against different variants: DRDO sci
Updated : 5 years, 2 months ago IST
New Delhi [India], May 8 (ANI): The Defence Research and Development Organisation (DRDO)'s new anti-COVID drug, just approved by the Drugs Controller General of India (DCGI) is effective against different variants of the coronavirus and helps in bringing patients out of oxygen support, sa
Read More
DCGI nods anti-COVID drug developed by DRDO for emergency use
Updated : 5 years, 2 months ago IST
New Delhi [India], May 8 (ANI): The Drugs Controller General of India (DCGI) has approved the emergency use of an anti-COVID drug - 2-deoxy-D-glucose (2-DG) - as an adjunct therapy in moderate to severe COVID-19 cases.
Read More
VINS Bioproducts gets DCGI nod to commence clinical trials for VINCOV-19
Updated : 5 years, 2 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): VINS Bioproducts on Monday received approval from the Drugs Controller General of India (DCGI) to commence the clinical trials for VINCOV-19, an antidote, and a cure against COVID-19, the Hyderabad based immunological company said.
Read More
SEC recommends authorisation to Covaxin without 'clinical trial mode'
Updated : 5 years, 4 months ago IST
New Delhi [India], March 10 (ANI): The Subject expert committee (SEC) of Drugs Controller General of India (DCGI) on Wednesday recommended removing the "clinical trial mode" condition related to Bharat Biotech's Covaxin.
Read More
Dr Reddy's initiates process for emergency use authorisation of Sputnik V
Updated : 5 years, 4 months ago IST
Hyderabad (Telangana) [India], Feb 19 (ANI): Dr Reddy's Laboratories said on Friday it has initiated the process with the Drugs Controller General of India (DCGI) for emergency use authorisation of human adenoviral vector-based platform vaccine candidate Sputnik V.
Read More
Serum Institute seeks DCGI nod for clinical trials of COVID-19 vaccine COV
Updated : 5 years, 5 months ago IST
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 vacci
Read More
Sputnik V meets primary endpoint of safety in phase 2 clinical trial in In
Updated : 5 years, 6 months ago IST
Hyderabad (Telangana) [India], January 12 (ANI): Dr Reddy's Laboratories has said that independent Data and Safety Monitoring Board (DSMB) reviewed the safety data from phase two clinical trial of Russia's Covid-19 vaccine Sputnik V and recommended phase three recruitment along with continui
Read More